Tigeryeah Capital
Hangzhoutigeryeah.com
Overview
Tigeryeah Capital is a venture capital firm and a holding subsidiary of Tigermed, focusing on investments in early and growth-stage companies in the medical and healthcare industry.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| QL Biopharm | Mar 2026 | Series C | Co-investor |
| Shanghai Best-Link Bioscience | Jan 2024 | Series B | Co-investor |
| Shanghai Best-Link Bioscience | Apr 2023 | Series A | Co-investor |
| Immorna | Feb 2023 | Series A Extension | Co-investor |
| Immorna Biotherapeutics | Feb 2023 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.